These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 15266516

  • 1. Long-term pharmacotherapy for obesity and overweight.
    Padwal R, Li SK, Lau DC.
    Cochrane Database Syst Rev; 2004; 2003(3):CD004094. PubMed ID: 15266516
    [Abstract] [Full Text] [Related]

  • 2. Long-term pharmacotherapy for obesity and overweight.
    Padwal R, Li SK, Lau DC.
    Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
    [Abstract] [Full Text] [Related]

  • 3. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials.
    Padwal R, Li SK, Lau DC.
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1437-46. PubMed ID: 12975638
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A, Jeitler K, Horvath K, Berghold A, Posch N, Meschik J, Semlitsch T.
    Cochrane Database Syst Rev; 2016 Mar 02; 3():CD007654. PubMed ID: 26934640
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, Semlitsch T.
    Cochrane Database Syst Rev; 2021 Jan 17; 1(1):CD007654. PubMed ID: 33454957
    [Abstract] [Full Text] [Related]

  • 7. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.
    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J.
    Cochrane Database Syst Rev; 2005 Jan 25; 2005(1):CD004096. PubMed ID: 15674929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
    García Díaz E, Martín Folgueras T.
    Nutr Hosp; 2011 Jan 25; 26(3):451-7. PubMed ID: 21892560
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis.
    Viner RM, Hsia Y, Tomsic T, Wong IC.
    Obes Rev; 2010 Aug 25; 11(8):593-602. PubMed ID: 19922432
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis.
    Johansson K, Neovius K, DeSantis SM, Rössner S, Neovius M.
    Obes Rev; 2009 Sep 25; 10(5):564-75. PubMed ID: 19460116
    [Abstract] [Full Text] [Related]

  • 17. Long term pharmacotherapy for obesity and overweight: updated meta-analysis.
    Rucker D, Padwal R, Li SK, Curioni C, Lau DC.
    BMJ; 2007 Dec 08; 335(7631):1194-9. PubMed ID: 18006966
    [Abstract] [Full Text] [Related]

  • 18. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
    Ara R, Blake L, Gray L, Hernández M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M, Abrams K, Cooper N, Davies M, Khunti K, Sutton A.
    Health Technol Assess; 2012 Dec 08; 16(5):iii-xiv, 1-195. PubMed ID: 22340890
    [Abstract] [Full Text] [Related]

  • 19. Long-term pharmacotherapy for obesity.
    Klein S.
    Obes Res; 2004 Dec 08; 12 Suppl():163S-6S. PubMed ID: 15687412
    [Abstract] [Full Text] [Related]

  • 20. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
    Richter WO.
    MMW Fortschr Med; 1999 Dec 09; 141(49-50):32-6. PubMed ID: 10726144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.